BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26724375)

  • 1. Platinum(II) phenanthroimidazole G-quadruplex ligand induces selective telomere shortening in A549 cancer cells.
    Mancini J; Rousseau P; Castor KJ; Sleiman HF; Autexier C
    Biochimie; 2016 Feb; 121():287-97. PubMed ID: 26724375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
    Taka T; Huang L; Wongnoppavich A; Tam-Chang SW; Lee TR; Tuntiwechapikul W
    Bioorg Med Chem; 2013 Feb; 21(4):883-90. PubMed ID: 23321015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a Platinum Complex to a G-Quadruplex Ligand Enhances Telomere Disruption.
    Charif R; Granotier-Beckers C; Bertrand HC; Poupon J; Ségal-Bendirdjian E; Teulade-Fichou MP; Boussin FD; Bombard S
    Chem Res Toxicol; 2017 Aug; 30(8):1629-1640. PubMed ID: 28657713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
    Huang FC; Chang CC; Lou PJ; Kuo IC; Chien CW; Chen CT; Shieh FY; Chang TC; Lin JJ
    Mol Cancer Res; 2008 Jun; 6(6):955-64. PubMed ID: 18515756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase.
    Gomez D; Aouali N; Renaud A; Douarre C; Shin-Ya K; Tazi J; Martinez S; Trentesaux C; Morjani H; Riou JF
    Cancer Res; 2003 Oct; 63(19):6149-53. PubMed ID: 14559794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new steroid derivative stabilizes g-quadruplexes and induces telomere uncapping in human tumor cells.
    Brassart B; Gomez D; De Cian A; Paterski R; Montagnac A; Qui KH; Temime-Smaali N; Trentesaux C; Mergny JL; Gueritte F; Riou JF
    Mol Pharmacol; 2007 Sep; 72(3):631-40. PubMed ID: 17586599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells.
    Zhou G; Liu X; Li Y; Xu S; Ma C; Wu X; Cheng Y; Yu Z; Zhao G; Chen Y
    Oncotarget; 2016 Mar; 7(12):14925-39. PubMed ID: 26908447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands.
    Riou JF; Guittat L; Mailliet P; Laoui A; Renou E; Petitgenet O; Mégnin-Chanet F; Hélène C; Mergny JL
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2672-7. PubMed ID: 11854467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Novel Schizocommunin Derivatives as Telomeric G-Quadruplex Ligands That Trigger Telomere Dysfunction and the Deoxyribonucleic Acid (DNA) Damage Response.
    Che T; Chen SB; Tu JL; Wang B; Wang YQ; Zhang Y; Wang J; Wang ZQ; Zhang ZP; Ou TM; Zhao Y; Tan JH; Huang ZS
    J Med Chem; 2018 Apr; 61(8):3436-3453. PubMed ID: 29618208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to the short term antiproliferative activity of the G-quadruplex ligand 12459 is associated with telomerase overexpression and telomere capping alteration.
    Gomez D; Aouali N; Londoño-Vallejo A; Lacroix L; Mégnin-Chanet F; Lemarteleur T; Douarre C; Shin-ya K; Mailliet P; Trentesaux C; Morjani H; Mergny JL; Riou JF
    J Biol Chem; 2003 Dec; 278(50):50554-62. PubMed ID: 14525974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.
    Liu R; Liu J; Wang S; Wang Y; Zhang T; Liu Y; Geng X; Wang F
    Cell Death Dis; 2019 Jul; 10(7):527. PubMed ID: 31296842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods of studying telomere damage induced by quadruplex-ligand complexes.
    Rizzo A; Salvati E; Biroccio A
    Methods; 2012 May; 57(1):93-9. PubMed ID: 22410593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
    Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
    Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands.
    Pennarun G; Granotier C; Gauthier LR; Gomez D; Hoffschir F; Mandine E; Riou JF; Mergny JL; Mailliet P; Boussin FD
    Oncogene; 2005 Apr; 24(18):2917-28. PubMed ID: 15735722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
    Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
    J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
    Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
    Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
    Kelland LR
    Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.
    Leonetti C; Amodei S; D'Angelo C; Rizzo A; Benassi B; Antonelli A; Elli R; Stevens MF; D'Incalci M; Zupi G; Biroccio A
    Mol Pharmacol; 2004 Nov; 66(5):1138-46. PubMed ID: 15304549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating Cancer by Targeting Telomeres and Telomerase.
    Ivancich M; Schrank Z; Wojdyla L; Leviskas B; Kuckovic A; Sanjali A; Puri N
    Antioxidants (Basel); 2017 Feb; 6(1):. PubMed ID: 28218725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere.
    Hu MH; Lin XT; Liu B; Tan JH
    Eur J Med Chem; 2020 Jan; 186():111891. PubMed ID: 31759730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.